The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Agios (Inst)
Outpatient blinatumomab with digital monitoring in patients with measurable residual disease positive (MRD+) B-ALL in a phase 4 study.
 
Timothy S. Pardee
Consulting or Advisory Role - Abbvie; Cornerstone Pharmaceuticals; Genentech
Research Funding - Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Named on a provisional patent on the use of KPC34 for the treatment of acute leukemias.
 
Juan Varela
Stock and Other Ownership Interests - NexImmune (Inst)
Honoraria - Kite, a Gilead Company (Inst); NexImmune (Inst)
Consulting or Advisory Role - NexImmune (Inst)
Speakers' Bureau - Kite, a Gilead Company (Inst)
 
Deepa Jeyakumar
Research Funding - Jazz Pharmaceuticals; Pfizer
 
Michael Kenneth Keng
No Relationships to Disclose
 
Michal Bar-Natan
No Relationships to Disclose
 
Krishna Gundabolu
Consulting or Advisory Role - Biomarin (Inst); Blueprint Medicines (Inst); BMS GmbH & Co. KG (Inst); Novartis (Inst)
 
Arlene Gayle
No Relationships to Disclose
 
Christopher McCann
Stock and Other Ownership Interests - Current Health (Inst)
 
Qing Xia
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Sofia Ganzha
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Noemi Mergen
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Faraz Zaman
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Paul R. Gordon
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Sharif S. Khan
No Relationships to Disclose